Specific clinical and anatomopathological characteristics of each case, such as the presentation with ataxia instead of dementia, or the presence or absence of tau inclusions, together with the biochemical characterization of the PrPSc in each case may shed some light on the potential existence of different strains responsible for the phenotypic heterogeneity. This evidence concerns the gene MAPT and dementia.